Fruit and vegetable intake modifies the associations between suppressor of cytokine signaling 3 genetic variants and type 2 diabetes

  • Xinling Qian
  • Xiaotian Liu
  • Zhenxing Mao
  • Tanko Abdulai
  • Xiaokang Dong
  • Runqi Tu
  • Yan Wang
  • Xue Liu
  • Zhicheng Luo
  • Dou Qiao
  • Chongjian WangEmail author
  • Yuqian LiEmail author
Original Contribution



Type 2 diabetes is a complex disease determined by variable genes and environmental factors. The study was designed to investigate the effect of interactions of four polymorphisms of suppressor of cytokine signaling 3 (SOCS3) with fruit and vegetable (F&V) intake on type 2 diabetes in a rural population of China.


A total of 4411 participants from the rural areas of Henan, China were included in the study. Multivariate logistic regression and restricted cubic splines were used to estimate the associations between polymorphisms and risk allele score of SOCS3 and type 2 diabetes in different groups. Haplotype analysis was conducted to examine the effects of linkage inheritance at these four loci on type 2 diabetes.


Three of the four polymorphisms showed significant associations with type 2 diabetes in the less F&V intake group after adjusting the covariates, the odds ratios (ORs) and corresponding 95% confidence intervals (95% CIs) were 1.24 (1.08–1.41) for rs4969168, 1.16 (1.02–1.32) for rs9892622, and 1.21 (1.06–1.39) for rs9914220. No significant association was detected in the more F&V intake group. The obvious dose–response relationship between the risk allele score and type 2 diabetes was also noted only in the less F&V intake group.


Variants of SOCS3 gene were associated with type 2 diabetes and the associations could be modified by the F&V intake.


Type 2 diabetes Fruit and vegetable SOCS3 Human 



This work was supported by the National Natural Science Foundation of China [Grant NO: 81602925, 81573243, U1304821], Foundation of National Key Program of Research and Development of China [Grant NO: 2016YFC0900803], Henan Provincial Science Fund for Distinguished Young Scholars [Grant NO: 164100510021], Science and Technology Innovation Talents Support Plan of Henan Province Colleges and Universities [Grant NO: 14HASTIT035], and High-level Personnel Special Support Project of Zhengzhou University [Grant NO: ZDGD13001]. The study sponsor was not involved in the design of the study; the collection, analysis, and interpretation of data; writing the report; or the decision to submit the report for publication.

Author contributions

CJW and YQL were responsible for the conception and design of the study. XLQ, XTL, CJW, and YQL were responsible for recruitment, cohort management, and experiment. XLQ and XTL were responsible for analyzing the data and the integrity and accuracy of the information. XLQ, XTL, ZXM, TA, XKD, RQT, YW, XL, ZCL, and DQ were responsible for the reagents/materials/analysis tools. XLQ, XTL, TA, CJW, and YQL were responsible for drafting and revising the manuscript. All authors read and approved the final manuscript.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

394_2020_2178_MOESM1_ESM.pdf (291 kb)
Supplementary file1 (PDF 290 kb)


  1. 1.
    Da Rocha FJ, Ogurtsova K, Linnenkamp U et al (2016) IDF Diabetes Atlas estimates of 2014 global health expenditures on diabetes. Diabetes Res Clin Pract 117:48–54. CrossRefGoogle Scholar
  2. 2.
    Yang W, Lu J, Weng J et al (2010) China National Diabetes And Metabolic Disorders study group. prevalence of diabetes among men and women in China. N Engl J Med 362:1090–1101. CrossRefPubMedGoogle Scholar
  3. 3.
    International Diabetes Federation (2018) IDF diabetes atlas-8th edition. Accessed 18 Oct 2018
  4. 4.
    Cooper AJ, Forouhi NG, Ye Z et al (2012) Fruit and vegetable intake and type2 diabetes: EPIC-InterAct prospective study and meta-analysis. Eur J Clin Nutr 66:1082–1092. CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Siegel KR, Bullard KM, Imperatore G et al (2018) Prevalence of major behavioral risk factors for type 2 diabetes. Diabetes Care 41:1032–1039. CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Talbert ME, Langefeld CD, Ziegler J et al (2009) Polymorphisms near SOCS3 are associated with obesity and glucose homeostasis traits in Hispanic Americans from the Insulin Resistance Atherosclerosis Family Study. Hum Genet 125:153–162. CrossRefPubMedGoogle Scholar
  7. 7.
    Mahony R, Ahmed S, Diskin C, Stevenson NJ (2016) SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use? Cell Mol Life Sci 73:3323–3336. CrossRefPubMedGoogle Scholar
  8. 8.
    Emanuelli B, Peraldi P, Filloux C et al (2001) SOCS-3 inhibits insulin signaling and is up-regulated in response to tumor necrosis factor-α in the adipose tissue of obese mice. J Biol Chem 276:47944–47949. CrossRefPubMedGoogle Scholar
  9. 9.
    Jamshidi Y, Snieder H, Wang X, Spector TD, Carter ND, O'Dell SD (2006) Common polymorphisms in SOCS3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins. Diabetologia 49:306–310. CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Fischer-Rosinsky A, Fisher E, Kovacs P et al (2008) Lack of association between the tagging SNP A+930RG of SOCS3 and type 2 diabetes mellitus: meta-analysis of four independent study populations. PLoS ONE 3:e3852. CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Tang W, Zou JJ, Chen XF et al (2011) Association of two polymorphisms within and near SOCS3 gene with obesity in three nationalities in Xinjiang province of China. Acta Pharmacol Sin 32:1381–1386. CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Li P, Tiwari HK, Lin WY et al (2014) Genetic association analysis of 30 genes related to obesity in a European American population. Int J Obes 38:724–729. CrossRefGoogle Scholar
  13. 13.
    Zheng YY, Wang LF, Fan XH et al (2013) Association of suppressor of cytokine signalling 3 polymorphisms with insulin resistance in patients with chronic hepatitis C. J Viral Hepat 20:273–280. CrossRefPubMedGoogle Scholar
  14. 14.
    Liu XT, Mao ZX, Li YQ et al (2019) The Henan Rural Cohort: a prospective study of chronic non-communicable diseases. Int J Epidemiol pii:dyz039. CrossRefGoogle Scholar
  15. 15.
    Perloff D, Grim C, Flack J et al (1993) Human blood pressure determination by sphygmomanometry. Circulation 88:2460–2470CrossRefGoogle Scholar
  16. 16.
    Fan M, Lyu J, He P (2014) Chinese guidelines for data processing and analysis concerning the International Physical Activity Questionnaire. Zhonghua Liu Xing Bing Xue Za Zhi 35:961–964PubMedGoogle Scholar
  17. 17.
    Yang YX, Zhang HM (2016) The dietary guidelines for Chinese residents (2016). Acta Nutr Sin 38:209–217. CrossRefGoogle Scholar
  18. 18.
    American Diabetes Association (2009) Diagnosis and classification of diabetes mellitus. Diabetes Care 32:S62–S67. CrossRefPubMedCentralGoogle Scholar
  19. 19.
    Desquilbet L, Mariotti F (2010) Dose-response analyses using restricted cubic spline functions in public health research. Stat Med 29:1037–1057. CrossRefPubMedGoogle Scholar
  20. 20.
    Lee DH, Keum N, Hu FB et al (2018) Comparison of the association of predicted fat mass, body mass index, and other obesity indicators with type 2 diabetes risk: two large prospective studies in US men and women. Eur J Epidemiol 33:1113–1123. CrossRefPubMedGoogle Scholar
  21. 21.
    Boeing H, Bechthold A, Bub A et al (2012) Critical review: vegetables and fruit in the prevention of chronic diseases. Nur J Nutr 51:637–663. CrossRefGoogle Scholar
  22. 22.
    World Health Organization (2003) Diet, nutrition and the prevention of chronic diseases. Report of a Joint WHO/FAO Expert Consulation, Geneva, Accessed 26 Oct 2019
  23. 23.
    Nilsson E, Jansson PA, Perfilyev A et al (2014) Altered DNA methylation and differential expression of genes influencing metabolism and inflammation in adipose tissue from subjects with type 2 diabetes. Diabetes 63:2962–2976. CrossRefPubMedGoogle Scholar
  24. 24.
    Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP (2013) Diabetes mellitus and inflammation. Curr Diabetes Rep 13:435–444. CrossRefGoogle Scholar
  25. 25.
    Mozaffarian D (2016) Dietary and policy priorities for cardiovascular disease, diabetes, and obesity a comprehensive review. Circulation 133:187–225. CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Dandona P, Aljada A, Chaudhuri A, Mohanty P, Garg R (2005) Metabolic syndrome: a comprehensive perspective based on interactions between obesity, diabetes, and inflammation. Circulation 111:1448–1454. CrossRefPubMedGoogle Scholar
  27. 27.
    Ghanim H, Abuaysheh S, Sia CL et al (2009) Increase in plasma endotoxin concentrations and the expression of toll-like receptors and suppressor of cytokine signaling-3 in mononuclear cells after a high-fat, high-carbohydrate meal: Implications for insulin resistance. Diabetes Care 32:2281–2287. CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Deopurkar R, Ghanim H, Friedman J et al (2010) Differential effects of cream, glucose, and orange juice on inflammation, endotoxin, and the expression of toll-like receptor-4 and suppressor of cytokine signaling-3. Diabetes Care 33:991–997. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Sass G, Shembade ND, Tiegs G (2005) Tumour necrosis factor alpha (TNF)-TNF receptor 1-inducible cytoprotective proteins in the mouse liver: relevance of suppressors of cytokine signalling. Biochem J 385:537–544. CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Stevenson NJ, Addley MR, Ryan EJ (2009) CCL11 blocks IL-4 and GM-CSF signaling in hematopoietic cells and hinders dendritic cell differentiation via suppressor of cytokine signaling expression. J Leukoc Biol 85:289–297. CrossRefPubMedGoogle Scholar
  31. 31.
    Darnell JE, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extra cellular signalin proteins. Science 264:1415–1421. CrossRefPubMedGoogle Scholar
  32. 32.
    O'Shea JJ, Notarangelo LD, Johnston JA, Candotti F (1997) Advances in the understanding of cytokine signal transduction: the role of Jaks and STATs in immunoregulation and the pathogenesis of immunodeficiency. J Clin Immunol 17:431–447CrossRefGoogle Scholar
  33. 33.
    Starr R, Willson TA, Viney EM et al (1997) A family of cytokine-inducible inhibitors of signalling. Nature 387:917–921CrossRefGoogle Scholar
  34. 34.
    Hilton DJ, Richardson RT, Alexander WS et al (1998) Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci USA 95:114–119CrossRefGoogle Scholar
  35. 35.
    Piessevaux J, Lavens D, Peelman F, Tavernier J (2008) The many faces of the SOCS box. Cytokine Growth Factor Rev 19:371–381. CrossRefPubMedGoogle Scholar
  36. 36.
    Tamiya T, Kashiwagi I, Takahashi R, Yasukawa H, Yoshimura A (2011) Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 31:980–985. CrossRefPubMedGoogle Scholar
  37. 37.
    White MF (1998) The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182:3–11CrossRefGoogle Scholar
  38. 38.
    Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E (2000) SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem 275:15958–15991. CrossRefGoogle Scholar
  39. 39.
    Shi H, Cave B, Inouye K, Bjørbaek C, Flier JS (2006) Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes 55:699–707. CrossRefPubMedGoogle Scholar
  40. 40.
    Heynsfield SB, Greenberg AS, Fujioka K et al (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose escalation trial. JAMA 282:1568–1575. CrossRefGoogle Scholar
  41. 41.
    Babon JJ, Kershaw NJ, Murphy JM et al (2012) Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity 36:239–250. CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Babon JJ, Nicola NA (2012) The biology and mechanism of action of suppressor of cytokine signaling 3. Growth Factors 30:207–219. CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Cooper AJ, Sharp SJ, Lentjes MA et al (2012) A prospective study of the association between quantity and variety of fruit and vegetable intake and incident type 2 diabetes. Diabetes Care 35:1293–1300. CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Ghanim H, Sia CL, Upadhyay M et al (2010) Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. Am J Clin Nutr 91:940–949. CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Sur I, Tuupanen S, Whitington T, Aaltonen LA, Taipale J (2013) Lessons from functional analysis of genome-wide association studies. Cancer Res 73:4180–4184. CrossRefPubMedGoogle Scholar
  46. 46.
    Oldridge DA, Wood AC, Weichert-Leahey N et al (2015) Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature 528:418–421. CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Melton C, Reuter JA, Spacek DV, Snyder M (2015) Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat Genet 47:710–716. CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

Authors and Affiliations

  1. 1.Department of Epidemiology and Biostatistics, College of Public HealthZhengzhou UniversityZhengzhouPeople’s Republic of China
  2. 2.Department of Clinical Pharmacology, School of Pharmaceutical ScienceZhengzhou UniversityZhengzhouPeople’s Republic of China

Personalised recommendations